NCT00002721View on ClinicalTrials.gov

Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 1995

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Prostate Cancer
Interventions
DRUG

doxorubicin hydrochloride

DRUG

estramustine phosphate sodium

PROCEDURE

drug resistance inhibition treatment

Trial Locations (1)

87131

University of New Mexico Cancer Research & Treatment Center, Albuquerque

All Listed Sponsors
lead

University of New Mexico

OTHER

NCT00002721 - Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter